Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Regulus Therapeutics (RGLS) Q3 2024 Earnings
RGLS
+0.66%
8
Aug
Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.4
-0.32
-0.23
-0.15
Details
Expected EPS
-0.146667
Actual EPS
-0.17
Surprise EPS
-0.02
Surprise Percent
+15.91%
Description
Regulus Therapeutics (RGLS) has reported earnings of -0.17 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login